Literature DB >> 407172

The pharmacology of methazolamide in relation to the treatment of glaucoma.

T H Maren, J R Haywood, S K Chapman, T J Zimmerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407172

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  10 in total

1.  Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.

Authors:  Malaz A AbuTarif; David R Taft
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study.

Authors:  F P Gunning; E L Greve; A M Bron; J M Bosc; J G Royer; J L George; P Lesure; D Sirbat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

3.  The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study.

Authors:  W Leydhecker; G K Krieglstein
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-04-02

4.  Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans.

Authors:  K R Sweeney; D J Chapron; E J Antal; P A Kramer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

5.  Effect of the application of acetazolamide soaked contact lenses on intraocular pressure of rabbits.

Authors:  A Temel; H Kazokoglu
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

6.  Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Authors:  Christina Lisk; Joe McCord; Swapan Bose; Tim Sullivan; Zoe Loomis; Eva Nozik-Grayck; Thies Schroeder; Karyn Hamilton; David C Irwin
Journal:  Free Radic Biol Med       Date:  2013-05-27       Impact factor: 7.376

7.  A comparative study of the kinetics of the Bohr effect in vertebrates.

Authors:  T H Maren; E R Swenson
Journal:  J Physiol       Date:  1980-06       Impact factor: 5.182

8.  Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

Authors:  John Youshia; Amany O Kamel; Abdelhameed El Shamy; Samar Mansour
Journal:  Int J Nanomedicine       Date:  2012-05-17

9.  Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.

Authors:  Wimonchat Tangamornsuksan; Manupat Lohitnavy
Journal:  Pharmacogenomics J       Date:  2018-09-21       Impact factor: 3.550

10.  Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.

Authors:  Nicky Konstantopoulos; Juan C Molero; Sean L McGee; Briana Spolding; Tim Connor; Melissa de Vries; Stephen Wanyonyi; Richard Fahey; Shona Morrison; Courtney Swinton; Sharon Jones; Adrian Cooper; Lucia Garcia-Guerra; Victoria C Foletta; Guy Krippner; Sofianos Andrikopoulos; Ken R Walder
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.